Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000153835 | SCV000203418 | benign | not specified | 2016-03-23 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000153835 | SCV000205268 | benign | not specified | 2013-10-11 | criteria provided, single submitter | clinical testing | Leu769Leu in exon 13 of RET: This variant is not expected to have clinical signi ficance because it has been identified in 23% (2018/8600) of European American c hromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/E VS/; dbSNP rs1800861). |
Labcorp Genetics |
RCV000860142 | SCV001000075 | benign | Multiple endocrine neoplasia, type 2 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001795273 | SCV002033568 | benign | Multiple endocrine neoplasia type 2A | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001795274 | SCV002033569 | benign | Multiple endocrine neoplasia type 2B | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001795272 | SCV002033570 | benign | Pheochromocytoma | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000860142 | SCV004357242 | benign | Multiple endocrine neoplasia, type 2 | 2019-03-28 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001727604 | SCV005319280 | benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000153835 | SCV001744320 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001727604 | SCV001974336 | likely benign | not provided | no assertion criteria provided | clinical testing |